Have your own idea? Try our Stock Screener
UPDATED Feb 20, 2025
Discover Swedish Healthcare Growth Stocks that are on the OMX. Sorted by forecasted growth, these Healthcare Stocks have higher than expected earnings or sales growth compared to other companies.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
DIGN | SEK 1.22 | 16.2% | -33.7% | SEK 98.3m | SEK 5.50 | PS1.1x | E118.7% | n/a | ||
NOSA | SEK 0.85 | -5.0% | 36.6% | SEK 179.7m | SEK 1.00 | PS11.2x | E103.4% | n/a | ||
ORT B | SEK 8.74 | 1.9% | -20.2% | SEK 324.1m | SEK 20.00 | PS5.1x | E96.6% | n/a | ||
BACTI B | SEK 30.30 | -0.7% | -57.3% | SEK 1.1b | SEK 47.50 | PS4.2x | E91.2% | n/a | ||
CARA | SEK 22.80 | -4.8% | n/a | SEK 1.6b | SEK 25.19 | PS6.3x | E89.1% | 7.7% | ||
BOUL | SEK 8.66 | -4.0% | -9.3% | SEK 336.3m | SEK 11.00 | PB1.2x | E88.8% | 0% | ||
SCIB | SEK 0.36 | -6.7% | -1.9% | SEK 79.5m | SEK 1.60 | PS3x | E87.7% | n/a | ||
SEZI | SEK 5.85 | 2.6% | -10.3% | SEK 779.1m | SEK 12.25 | PS13.3x | E86.2% | n/a | ||
KONT | SEK 2.46 | 0.8% | 6.5% | SEK 86.7m | SEK 5.20 | PE111.9x | E82.0% | n/a | ||
ACARIX | SEK 0.23 | 0.2% | -14.6% | SEK 242.0m | n/a | PS39x | E78.8% | n/a | ||
INTEG B | SEK 16.35 | -5.5% | -58.6% | SEK 317.1m | SEK 39.75 | PS3x | E69.4% | n/a | ||
OSSD | SEK 13.48 | 9.1% | 54.6% | SEK 1.3b | SEK 13.00 | PS9.8x | E68.9% | n/a | ||
CLS B | SEK 3.36 | -15.2% | -81.3% | SEK 67.8m | SEK 14.00 | PS3.6x | E63.8% | n/a | ||
PAX | SEK 69.60 | 5.1% | 89.6% | SEK 1.3b | SEK 80.00 | PE50.4x | E60.8% | n/a | ||
EQL | SEK 83.80 | -4.6% | 116.5% | SEK 2.4b | SEK 77.50 | PE70.1x | E56.1% | n/a | ||
IMP A SDB | SEK 36.45 | -8.9% | 25.9% | SEK 10.3b | SEK 53.87 | PS479.4x | E53.6% | n/a | ||
MNTC | SEK 21.60 | -10.0% | -36.8% | SEK 552.3m | SEK 41.75 | PS1.9x | E48.2% | 0% | ||
QLINEA | SEK 0.058 | -85.0% | -97.4% | SEK 242.1m | SEK 7.00 | PS69.2x | E47.9% | n/a | ||
SYNT | SEK 27.70 | 0% | -13.4% | SEK 1.2b | SEK 30.00 | PE115.3x | E47.4% | 0% | ||
VIMIAN | SEK 43.40 | -5.5% | 50.6% | SEK 22.7b | SEK 46.63 | PE110.4x | E44.3% | n/a | ||
MEDHLP | SEK 3.36 | 1.8% | -3.7% | SEK 102.3m | SEK 5.70 | PE48.3x | E42.3% | n/a | ||
XVIVO | SEK 458.50 | -3.9% | 75.7% | SEK 14.4b | SEK 518.67 | PE83.9x | E39.2% | n/a | ||
IRRAS | SEK 0.16 | -1.1% | -64.4% | SEK 181.7m | SEK 2.58 | PS4.2x | E38.8% | n/a | ||
SUS | SEK 159.40 | -15.9% | 2.8% | SEK 8.1b | SEK 193.00 | PE61.8x | E36.7% | n/a |